Quick Answer
Panax Ginseng Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Methods We performed a systematic review and meta-analysis to quantitatively synthesize randomized controlled trial evidence on the efficacy of phytotherapeutic interventions for cancer-related fatigue and to assess the certainty of evidence.
Key Takeaways
- 01Methods We performed a systematic review and meta-analysis to quantitatively synthesize randomized controlled trial evidence on the efficacy of phytotherapeutic interventions for cancer-related fatigue and to assess the certainty of evidence. [Matsas S (2026)]
- 02We also evaluated risk of bias (RoB 2), publication bias, and certainty of evidence using GRADE. [Matsas S (2026)]
- 03Most trials had high or unclear risk of bias, and the certainty of evidence was rated very low. [Matsas S (2026)]
- 04Background Cancer-related fatigue (CRF) is one of the most common and burdensome symptoms faced by patients with cancer, yet effective drug-based treatments remain limited. [Matsas S (2026)]
The current Migaku evidence database contains 2 reusable source documents for Panax Ginseng Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Methods We performed a systematic review and meta-analysis to quantitatively synthesize randomized controlled trial evidence on the efficacy of phytotherapeutic interventions for cancer-related fatigue and to assess the certainty of evidence. [Matsas S (2026); evidence level 1]
- We also evaluated risk of bias (RoB 2), publication bias, and certainty of evidence using GRADE. [Matsas S (2026); evidence level 1]
- Most trials had high or unclear risk of bias, and the certainty of evidence was rated very low. [Matsas S (2026); evidence level 1]
- Background Cancer-related fatigue (CRF) is one of the most common and burdensome symptoms faced by patients with cancer, yet effective drug-based treatments remain limited. [Matsas S (2026); evidence level 1]
- Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. [Cortés Hernán (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources